1. Home
  2. SCNI vs ASST Comparison

SCNI vs ASST Comparison

Compare SCNI & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • ASST
  • Stock Information
  • Founded
  • SCNI 2003
  • ASST 2020
  • Country
  • SCNI Israel
  • ASST United States
  • Employees
  • SCNI N/A
  • ASST N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • ASST Computer Software: Prepackaged Software
  • Sector
  • SCNI Health Care
  • ASST Technology
  • Exchange
  • SCNI Nasdaq
  • ASST Nasdaq
  • Market Cap
  • SCNI 3.5M
  • ASST 3.6M
  • IPO Year
  • SCNI N/A
  • ASST 2023
  • Fundamental
  • Price
  • SCNI $2.84
  • ASST $0.66
  • Analyst Decision
  • SCNI
  • ASST
  • Analyst Count
  • SCNI 0
  • ASST 0
  • Target Price
  • SCNI N/A
  • ASST N/A
  • AVG Volume (30 Days)
  • SCNI 12.9K
  • ASST 1.3M
  • Earning Date
  • SCNI 11-29-2024
  • ASST 11-29-2024
  • Dividend Yield
  • SCNI N/A
  • ASST N/A
  • EPS Growth
  • SCNI N/A
  • ASST N/A
  • EPS
  • SCNI N/A
  • ASST N/A
  • Revenue
  • SCNI $284,000.00
  • ASST $501,584.00
  • Revenue This Year
  • SCNI N/A
  • ASST N/A
  • Revenue Next Year
  • SCNI N/A
  • ASST N/A
  • P/E Ratio
  • SCNI N/A
  • ASST N/A
  • Revenue Growth
  • SCNI N/A
  • ASST 93.55
  • 52 Week Low
  • SCNI $2.23
  • ASST $0.61
  • 52 Week High
  • SCNI $8.92
  • ASST $5.10
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 30.31
  • ASST 28.96
  • Support Level
  • SCNI $2.91
  • ASST $0.61
  • Resistance Level
  • SCNI $3.70
  • ASST $0.84
  • Average True Range (ATR)
  • SCNI 0.21
  • ASST 0.09
  • MACD
  • SCNI -0.07
  • ASST -0.00
  • Stochastic Oscillator
  • SCNI 7.37
  • ASST 9.84

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About ASST Asset Entities Inc. Class B

Asset Entities Inc is an Internet company providing social media marketing, content delivery, and development and design services across Discord, TikTok, and other social media platforms. It has three categories of services: 1) provide subscription upgrades to premium content on investment education and entertainment servers on Discord. 2) codevelop and execute influencer social media and marketing campaigns for clients. 3) design, develop and manage Discord servers for clients under "AE.360.DDM" brand.

Share on Social Networks: